Transcultural and Psychometric Validation of the Lubben Social Network Scale in Older Adults Living in the French West Indies
NCT ID: NCT06909591
Last Updated: 2025-06-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
150 participants
OBSERVATIONAL
2025-09-01
2027-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
To date, there is no tool to measure social isolation and loneliness for patients living in the French West Indies. Applying unadapted and unvalidated tools to them without taking into account local ethnocultural realities would be risky.
The investigators believe it is necessary to adapt the scales used to measure social isolation and loneliness for a population living in the French West Indies.
Through this study, the investigators propose adapting the Lubben Social Network Scale, a social isolation questionnaire, for this population and conducting its psychometric validation.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Establishing Social Connections in Urban Areas: Evaluating a Community-based Programme
NCT06805136
Community Intervention to Reduce Social Isolation in Elderly People: a Mixed Methods Multi-approach Evaluation
NCT03142048
Evaluating Quebec's Red-Cross Intervention
NCT05099042
Evaluation of Rupture of Galenic Practices at Home in a Population Aged 65 or Older
NCT03681899
Compartiendo Salud: Community-Based Intervention for Loneliness
NCT06829758
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Loneliness is a subjective concept of social relationships, most often reflecting a negative feeling.
Social isolation, on the other hand, is an objective concept of social relationships and refers to infrequent or rare contact with family and friends and can also include living alone.
The feeling of loneliness is linked to social isolation, although the association is only partial.
Indeed, some socially isolated people do not always experience loneliness; and some people living alone are not always socially isolated.
Two theories of loneliness argue that a mismatch between expectations and realities of social contact (cognitive theory) and a lack of intimate or social relationships (deficit theory) can lead to feelings of social or emotional loneliness.
A meta-analysis showed that the risk of premature death was 26% higher in people experiencing loneliness, 29% higher in those who were socially isolated, and 32% higher in the group living alone.
Another meta-analysis examined the effects of loneliness and social isolation on (among other things) mortality. The results showed that loneliness and social isolation were significantly associated with an increased risk of mortality.
The authors conclude that further research is needed to confirm whether loneliness and social isolation have a direct impact on mortality, or whether the association is indirect via the cardiovascular system and psychological health.
To date, there is no tool to measure social isolation and loneliness for patients living in the French West Indies. Applying unsuitable and unvalidated tools to them without taking into account local ethnocultural realities would be risky.
The investigators believe it is necessary to adapt the scales used to measure social isolation and loneliness for a population living in the French West Indies.
Through this study, the investigators propose adapting the Lubben Social Network Scale, a social isolation questionnaire, for this population and conducting its psychometric validation.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients aged 65 or older
For the transcultural validation, a french version of the Lubben Social Network Scale questionnaire will be produced. For the psychometric validation, 150 patients aged of 65 or older will pass the questionnaire. The Duke Health Profile questionnaire will be also passed by the subject, for the convergent validity.
Self-assessment questionnaire
150 patients aged of 65 or older will pass the Lubben Social Network Scale questionnaire. The Duke Health Profile questionnaire will be also passed by the subject, for the convergent validity.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Self-assessment questionnaire
150 patients aged of 65 or older will pass the Lubben Social Network Scale questionnaire. The Duke Health Profile questionnaire will be also passed by the subject, for the convergent validity.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Hospitalized (Geriatric Day Hospital (HDJ) or Geriatric Medical Care and Rehabilitation Service (SMT)), or seen in geriatric external consultation,
* MMS ≥ 20,
* Patient able to understand and answer a self-administered questionnaire in French,
* Patient having been informed of the research,
* Patient agreeing to participate in the study.
Exclusion Criteria
* Patient unable to consent to participate in the study,
* Patient under legal protection, guardianship, or curatorship,
* Patient who has refused to participate in the study.
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital Center of Martinique
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU of Martinique
Fort-de-France, , Martinique
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2024-A02609-38
Identifier Type: REGISTRY
Identifier Source: secondary_id
24_RIPH3-05
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.